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Genetic analysis in Drosophila melanogaster has been widely used to identify a system of genes that
control cell growth in response to insulin and nutrients. Many of these genes encode components
of the insulin receptor/target of rapamycin (InR/TOR) pathway. However, the biochemical context
of this regulatory system is still poorly characterized in Drosophila. Here, we present the first
quantitative study that systematically characterizes the modularity and hormone sensitivity of the
interaction proteome underlying growth control by the dInR/TOR pathway. Applying quantitative
affinity purification and mass spectrometry, we identified 97 high confidence protein interactions
among 58 network components. In all, 22% of the detected interactions were regulated by insulin
affecting membrane proximal as well as intracellular signaling complexes. Systematic functional
analysis linked a subset of network components to the control of dTORC1 and dTORC2 activity.
Furthermore, our data suggest the presence of three distinct dTOR kinase complexes, including the
evolutionary conserved dTTTcomplex (Drosophila TOR, TELO2, TTI1). Subsequent genetic studies
in flies suggest a role for dTTT in controlling cell growth via a dTORC1- and dTORC2-dependent
mechanism.
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Introduction
The control of cellular growth requires an intricate system of
molecular mechanisms that orchestrate processes such as
translation, cellular proliferation, apoptosis and autophagy in
response to the nutritional and humoral environment of the
cell. Genetic screens in Drosophila have frequently been used
to identify key regulators of cell growth. Subsequent analyses
of their functional relationships led to pathwaymodels such as
the insulin receptor and target of rapamycin (InR/TOR)
pathway. However, a detailed molecular understanding of
how a particular growth phenotype results from a specific
genotype has remained largely elusive.
Biological processes, including cell growth, emerge from
molecular networks involving proteins, which stably and/or
transiently interact to form protein complexes that in turn
organize in extended interaction networks. In most cases, it is
therefore conceivable that growth phenotypes are the result of
mutations affecting the function of proteins and thereby
perturbing network states. The systematic analysis of the
composition and dynamics of such protein interaction net-
works is therefore highly relevant for a systems level under-
standing on the molecular organization of cell growth control.
Affinity purification coupled with tandem mass spectrometry
(AP–MS/MS) is the most advanced method to characterize
protein complexes and it has already revealed important
insights into themodular organization of the proteome in yeast
(Gavin et al, 2002; Krogan et al, 2006) and other species
(Butland et al, 2005; Kuhner et al, 2009).
Signaling networks are highly dynamic and assemble or
disassemble in response to changes in the cellular environ-
ment. However, most existing models on protein interaction
networks are typically represented as static entities due to lack
of quantitative MS information. Subsequent functional studies
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of AP–MS data represent key steps to develop new hypotheses
on how biological processes emerge from biochemical net-
works. In this regard, Drosophila could provide a major
advantage as it offers a number of unique genetic tools to
characterize functional relevance of identified network com-
ponents. However, surprisingly little protein interaction
information has so far been reported using systematic
AP–MS in Drosophila.
In this study, we present the first systematic quantitative
AP–MS/MS analysis on the Drosophila InR/TOR pathway, an
evolutionarily conserved growth regulating signaling system
that has been linked to a number of severe human diseases
such as cancer or diabetes (Saltiel and Kahn, 2001; Biddinger
and Kahn, 2006; Zoncu et al, 2011). We studied the complexes
around 16 bait proteins including membrane proximal
signaling proteins, intracellular regulators as well as known
effectors of this pathway. In all, 22% of the high confidence
interactions identified turned out to be regulated by insulin,
suggesting that the network as awhole is substantially affected
by the activity state of the InR. High-density protein interaction
data revealed a highly modular organization of the Drosophila
TOR kinase interactome consistent with the existence of
several distinct TOR complexes. Subsequent systematic func-
tional experiments using RNA interference against all network
components suggest that a significant fraction of these compo-
nents can be functionally linked to the control of dTORC1 and
dTORC2 activity. Among these we identified two components
of the dTTT complex, which when mutated caused a similar
growth phenotype as dTOR mutant flies. Taken together, these
results illustrate how quantitative AP–MS when combined
with systematic functional analysis in Drosophila can reveal
novel insights into the dynamic organization of regulatory
networks for cell growth control in metazoans.
Results
Systematic analysis of the InR/TOR interaction
proteome
We selected 16 bait proteins that were previously linked by
genetic or biochemical evidence to growth control by the InR/
TOR pathway. Affinity-tagged versions of these proteins
were inducibly expressed in stably transfected Drosophila
Kc167 cell lines. To study hormone-induced remodeling of
signaling complexes at the pathway level, we performed APs
of protein complexes under insulin-stimulated and -non-
stimulated conditions. The experimental workflow is depicted
in Figure 1A and bait proteins are listed in Supplementary
Table 1.
To discriminate between true and false protein interactors
from the initially generated protein list, we used the recently
introduced Significance Analysis of INTeractome (SAINT) 2.0
algorithm (Choi et al, 2010) (Figure 1B; for details seeMaterials
and methods). Stringent filtering resulted in a final high
confidence protein interaction (HCPI) data set containing 58
network components and 97 interactions (Supplementary
Tables 2–4). Figure 1C illustrates the result of filtering raw data
from dTOR purifications using the SAINT score.
We compared our HCPI data with known interaction infor-
mation available from the literature and protein interaction
databases for Drosophila, yeast and humans (Figure 1D;
Supplementary Table 5). Twelve interactions were already
known from previous Drosophila studies. Of the 85 remaining
interactions, 39 had been previously described among human
orthologs. In all, 10 of these conserved interactions were also
represented in the known yeast interaction proteome. These
highly conserved interactions constitute the TORC1 and
TORC2 complexes in the respective species (for details see
also Supplementary Table 5). Protein interactions from our
data set that were conserved in human, but not in yeast,
centered around the InR signaling components, which are
absent in yeast. Previous large-scale yeast two-hybrid studies
on the Drosophila interaction proteome captured only three of
the detected interactions, highlighting the need for AP–MS-
based interaction proteomics for cell signaling research in
Drosophila. In addition to these known interactions, we also
found 46 novel interactions, which provide interesting entry
points into further functional studies on the signaling mecha-
nism underlying cell growth control by the InR/TOR signaling
system and will be discussed later in the text.
Identification of insulin-modulated changes in the
InR/TOR interaction proteome by quantitative MS
To systematically analyze insulin-modulated changes in the
InR/TOR interaction network, we purified all protein com-
plexes from insulin-treated or -untreated cells and quantified
the abundance of the interacting proteins using label-free
quantification (Rinner et al, 2007) (Figure 2A). The measured
profiles from two replicate experiments quantified 86 out of 97
interactions identified (for detailed information see Materials
and methods). Based on the distribution of average enrich-
ment factors (AEF) (Figure 2B), interactions were specified as
insulin sensitivewhen their measured fold-change was at least
1.5 in two independent experiments. The validity of a 1.5-fold
cutoff was carefully evaluated by statistical analysis of
controlled dilution experiments (Supplementary Figure 1;
Supplementary Table 9). Using these criteria, we identified a
total of 22 insulin-regulated interactions, corresponding to
25% of the quantified InR/TOR interaction proteome
(Figure 2D; Supplementary Tables 6 and 7).
Membrane proximal signaling events around the activated
InR complex illustrate how results from this quantitative
approach can be used to specify insulin-sensitive and
-insensitive interactions (Figure 2C). We found that the
association of the InR substrate (IRS) homolog Chico with
the regulatory phosphatidylinositol 3-(PI3) kinase subunit p60
(Pi3K21B) was highly induced upon insulin stimulation
(Figure 2C, left panel). In contrast, the E3 ubiquitin ligase
Mindbomb-2 (Mib-2) dissociated from Chico upon insulin
treatment. Reciprocal experiments using p60 as a bait
confirmed insulin inducible binding of p60 to Chico
(Figure 2C, right panel) and revealed insulin-sensitive inter-
actions with dInR and CG11063. The interaction of p60 with
other binding partners including PDGF/VEGF receptor homo-
log Pvr, Lin19 and dp110 (Pi3K92E), was not affected by
insulin. Insulin-sensitive remodeling of the InR/TOR interac-
tion proteome was not restricted to the membrane proximal
InR/PI3K complexes but expands also toward downstream
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pathway regulators, which are listed in Figure 2D and
discussed in more detail below.
Overview on the Drosophila InR/TOR pathway
interactome
Wenext assembled the interaction data (Supplementary Tables
2 and 6) into a quantitative networkmodel to identify signaling
modules and their changes upon insulin treatment (Figure 3).
The term module is defined here as a group of proteins with
high connectivity in the interaction network model due to
complex formation or sharing of binding partners, indicating a
related biochemical context. Overall, the resulting network
was enriched for proteins with roles in cell signaling processes
such as ubiquitin-dependent degradation, protein phosphor-
ylation, GTPase signaling, transcription and translation. Using
functional annotations and the obtained network topology,
we grouped the network components into four functional
modules: (1) the membrane proximal InR module, (2) the
tuberous sclerosis complex (TSC), (3) the group of 14-3-3
complexes and (4) the TOR module. Selected interactions
within these modules are described below in more detail.
New molecular components within the Drosophila InR
module
Besides the insulin-dependent interactions between the core
components dInR, Chico and the PI3K subunits dp110 and p60,
we identified a number of new interactions with potential
interest for the regulation of this essential module in the InR/
TOR pathway. Chico and the regulatory subunit of PI3K (p60)
interacted with distinct E3 ligases. These previously unde-
tected interactions suggest the involvement of several ubiqui-
tin-dependent processes for membrane proximal signaling
events. Specifically, Chico was found in association with the
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Figure 1 Overview on the experimental workflow and data processing. (A) Experimental workflow. In all, 16 genes linked to dInR/TOR pathway were PCR amplified
from cDNA pools. By recombinatorial cloning, the Drosophila ORFs were transferred into an in-house designed expression vector for inducible expression of epitope-
tagged bait proteins. Bait expression was induced and cells were starved overnight in 2% FBS. Half of the cell population was exposed to 100 nM insulin for 20 min. The
cells were lysed in the presence of DSP cross-linker and bait proteins were purified by anti-HA AP. All AP–MS/MS experiments were performed as two independent
replicates. (B) Data processing of the AP–MS/MS data set for detection of specific PPIs using the SAINT algorithm. Following database search, spectrum counts for
each identified protein were extracted from the LC–MS/MS data. Based on normalized spectrum counts, SAINT models the spectrum count distribution of each bait–prey
interaction and calculates scores based on the relative abundance of each hit. In all, 24 independently control AP–MS experiments (using GFP as a bait protein) were
performed in parallel to model false interaction distribution. (C) SAINT scores (data from two biological replicates) were plotted from dTOR purified in the absence (x axis)
or the presence (y axis) of insulin to illustrate the specificity increase by the SAINT filtering approach. (D) Overlap with orthologous PPI data and known Drosophila PPIs.
The PPI data obtained in this study were compared with available literature and database information covering known D. melanogaster and related Homo sapiens
interactions (see also Materials and methods).
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RING-finger domain containing E3 ligaseMib-2, an association
that was decreased upon insulin treatment; the PI3K regula-
tory subunit p60 copurifiedwith SkpA, Lin19, Pall, which have
been shown to form an SCF (Skp1, Cullin, F-box) E3 ubiquitin
ligase complex (Silva et al, 2007), consistent with the view that
the entire SCF complex is associated with p60. In contrast to
the Chico–Mib-2 interaction, the p60-SCFPal1 interaction was
not affected by insulin.
Besides binding to the dInR, we found p60 also associated
with Pvr, another receptor tyrosine kinase related to the
human VEGF and PDGF receptor. In contrast to the p60–dInR
interaction, which was strongly enhanced upon insulin, the
p60–Pvr interaction was not affected by insulin. Thus, at least
under the applied experimental conditions, insulin-induced
recruitment of p60 to the dInR does not interfere with p60
binding to Pvr and maybe other RTKs. The catalytic subunit of
PI3K dp110 was found in complexes with Rho-type GTPase
exchange factor and the ARF GTPase-activating protein GIT
(CG16728), suggesting a role of PI3K for specific GTPase
controlled signaling events in Drosophila.
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Unk CG3004 (dGβL) — 0.77 0.60 1.60
Unk Tor Target of rapamycin 0.74 0.68 1.70
Raptor Unk Unkempt 0.92 0.81 1.86
S6k Raptor Raptor 0.66 0.60 1.96
Thor Tor Target of rapamycin 0.75 0.52 2.14
Tor Unk Unkempt 0.93 0.98 3.06
Sin1 14-3-3epsilon 14-3-3epsilon 0.96 0.88 4.11
Thor Unk Unkempt 0.66 0.92 4.42
Pi3K21B jub Ajuba LIM protein 0.92 0.98 4.49
Sin1 msn Misshapen 0.98 0.71 5.07
foxo 14-3-3epsilon 14-3-3epsilon 0.88 0.95 6.25
foxo 14-3-3zeta 14-3-3zeta 0.90 0.94 6.43
Pi3K21B InR Insulin-like receptor 0.99 0.99 10.00
Pi3K21B chico Chico 0.98 0.99 10.00
Chico Pi3K21B Pi3K21B 0.99 0.99 10.00
Thor L Lobe 0.70 0.99 0.26
Thor eIF-4E Eukaryotic initiation factor 4E 0.76 0.85 0.27
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Tor L Lobe 0.90 0.86 0.36
CG3004 (dGβL) L Lobe 0.73 0.96 0.38
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Figure 2 Quantitative analysis of insulin-sensitive PPIs. (A) Schematic overview on the experimental approach for monitoring insulin-sensitive bait–prey interactions
using label-free MS and MS1 alignment (for details see Materials and methods). (B) Examples of dilution experiments in combination with label-free quantification and
multiple LC–MS alignment. AP–MS analysis was performed on insulin-treated and -untreated Kc167 cell lines expressing Chico (dIRS) and p60 (Pi3K21B). Protein
abundance profiles were normalized against the individual bait profiles of Chico and p60 (black lines). Bait–prey interactions showing changes in abundance upon insulin
stimulation are presented as red (increase) and blue (decrease) profiles. Lines in green refer to unaffected protein interactions. Error bars indicate s.e.m. of the average
MS1 signal intensity of an individual profile in a particular dilution. (C) Overview on enrichment factor distribution of all quantified protein interactions. The average
enrichment factor (AEF) of every PPI were calculated from replicate experiments and plotted over the entire data set. All interactions with a SAINT score 40.8 are
shown (see also Materials and methods). (D) List of all observed insulin-sensitive interactions. Pearson product-moment coefficient from linear regression analysis (r) as
well as AEF calculated based on profile information between two replicates (Exp. A and B, respectively) are listed.
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The Drosophila TSC
Next to the InR module, the TSC module is of particular
importance for the regulation of TOR activity. dTSC1 and Gigas
(dTSC2, gig), the Drosophila ortholog of human TSC2, as
expected form heterodimers (van Slegtenhorst et al, 1998).
It has been shown that TSC2 can repress the activity of the Ras-
related GTPase Rheb via its associated GAP domain (GTPase-
activating protein), resulting in the inactivation of TOR (Garami
et al, 2003; Stocker et al, 2003). Consistently, we found Rheb
stably associated with the dTSC complex. Remarkably, we
identified another GAP domain protein, the gene product of
CG6182, in complexeswith dTSC1 and dTSC2. Themammalian
ortholog of this protein, TBC1D7, associates with human TSC1,
indicating that this interaction is conserved (Nakashima et al,
2007). It has been proposed that TBC1D7 may increase TORC1
activity toward S6K (S6 Kinase) via ubiquitin-mediated
degradation of the TSC dimer (Nakashima et al, 2007).
Recently, TBC1D7 expression has been associated with poor
prognosis for pulmonary carcinogenesis (Sato et al, 2010).
Besides the association with GTPase signaling components,
we found TSC1 in complexes with CG43143, the Drosophila
homolog of NUAK1/ARK5, a so far poorly characterized
kinase that is related to AMPK (adenosine monophosphate-
activated protein kinase). The finding that the human TSC
complex is regulated via AMPK (Inoki et al, 2003; Corradetti
et al, 2004) further supports a potential new functional link
between the NUAK1 homolog and the Drosophila TSC
complex.
14-3-3 Complexes in the dInR/TOR pathway
14-3-3 proteins have been implicated in the regulation of a
number of signaling pathways, including the InR/TOR path-
way (Morrison, 2009). It is believed that phosphorylation-
dependent binding of 14-3-3 proteins regulate stability,
localization and activity of the bound proteins (Morrison,
2009). We found both 14-3-3e and 14-3-3z in complexes with
Chico, dTSC1, dTSC2, dRictor, dSIN1 and dFoxo. 14-3-3
TSCInR/PI3K
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Figure 3 Modularity and insulin sensitivity of the dInR/TOR interaction proteome. High confidence PPI data are visualized using Cytoscape v2.8.1. Bait proteins are
represented as hexagons, preys as circles. Names correspond to flybase gene symbols. Interactions that are increased or decreased upon insulin treatment are
represented with arrow symbols and edge colors as indicated. Nodes have been color coded according to the functional classification given in the pie chart. Proteins are
grouped into functional modules based on prior knowledge and network topology.
The D. melanogaster InR/TOR pathway interaction proteme
T Glatter et al
& 2011 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2011 5
complexes containing dFoxo or dSIN1 were most strongly
affected by insulin stimulation. It was proposed that 14-3-3
binding sequesters Foxo transcription factors in the cytoplasm
upon activation of the InR pathway (Brunet et al, 2002; Rinner
et al, 2007). Binding of 14-3-3 proteins to the dTORC2
components dRictor or dSIN1, as shown here, has so far not
been observed in Drosophila. dRictor has several predicted
14-3-3 binding sites and recent studies demonstrated 14-3-3
protein binding to Rictor in human cells (Dibble et al, 2009).
Drosophila TOR modules
The TOR kinase dTOR represents a central node in the growth
control network. It integrates various signaling inputs includ-
ing nutrient availability and insulin signaling, energy status
and oxygen availability. Surprisingly little is known about the
Drosophila TOR interaction proteome. To obtain a compre-
hensive representation of Drosophila TOR complexes, we
selected the seven fly proteins as baits for AP–MS analysis that
are homologous to human proteins implicated in the forma-
tion of TORC1 and TORC2 complexes (dTOR, dRaptor, dGbL/
CG3004, dRictor, dSIN1) or act as downstream effectors
(Thor/d4E-BP and dS6K). In addition, we included Unkempt
(Unk) and the product of CG16908, two proteins that we
identified in dTOR purifications and which have not been
linked to mTORC1 or mTORC2 in previous studies. As a result,
we obtained a highly interconnected subnetwork composed of
established TOR signaling components known from studies in
other species and proteins that have not been implicated in
TOR signaling yet. All orthologous components of mTORC1
and mTORC2 complexes in Drosophila (dGbL, Lobe, dRaptor,
dRictor and dSIN1) including the TORC1 substrates d4E-BP
(Thor) and S6K were found to form complexes with dTOR.
The resulting network topology is consistent with the
existence of evolutionary conserved dTORC1 and dTORC2
complexes in Drosophila, for example, when the dTORC1-
specific protein dRaptor was used as a bait, only TORC1
proteins, but no TORC2 proteins, such as dRictor and dSIN1,
were identified by shotgun proteomics. Likewise, AP–MS
analysis of dRictor purifications did not reveal any dTORC1-
specific components. The only exception was found when
dSIN1 was used as a bait. Besides the expected dTORC2
proteins dTOR, dRictor and dGbL, we also found dRaptor. This
may suggest that under the applied conditions, a fraction of
dSIN1 may exist in complexes containing the TORC1 protein
dRaptor.
From the identified core components, Lobe, the Drosophila
ortholog of human PRAS40, was consistently reduced in
dTOR, dRaptor, dGbL or Thor/d4E-BP purifications from
insulin-treated cells.
Among the proteins that showed increased complex forma-
tion with dTOR upon insulin signaling, we identified the
dTORC1 substrates d4E-BP, dS6K as well as Unk, a poorly
characterized ring-finger protein with a proposed role in
ubiquitin-mediated protein degradation (Lores et al, 2010).
Insulin increased complex formation of Unk with a number of
dTORC1 components, suggesting that Unk represents a novel
insulin-sensitive component of dTORC1.
A specific set of proteins that were not linked to the
canonical TOR complexes TORC1 and TORC2 were found in
dTOR purifications. These include LqfR (liquid facets related),
Pontin, Reptin, Spaghetti and the gene product of CG16908.We
confirmed these interactions by reciprocal purification using
CG16908 as bait. However, none of the dTORC1/2 components
besides dTOR was identified in CG16908 purifications,
indicating that these proteins form dTOR complexes distinct
from dTORC1 and dTORC2. Sequence analysis revealed that
LqfR and CG16908 encode proteins with homologies to human
and Tel2 (see Supplementary Figure 2) and Tti1 (Kaizuka et al,
2010). Tel2 can form complexes with Tti1 and phosphatidyli-
nositol 3-kinase-related protein kinases including TOR in yeast
and mammalian cells (Hurov et al, 2010; Kaizuka et al, 2010).
Consistent with this notion, we found besides dTOR also
Nipped-A, the Drosophila homolog of the human PIK-related
kinase TRAPP in CG16908 purifications. Based on the
observed network topology and the homology to the proteins
observed in human Tel2 complexes, we refer to this complex
as dTTT complex (dTOR–dTel2–dTti1). In contrast to the
dTORC1 interactions, we found that the level of dTTT
components was not affected in dTOR purifications following
insulin treatment.
Taken together, the high-density interaction data obtained in
this study are consistent with the model that dTOR can form at
least three major complexes (dTORC1, dTORC2 and dTTT), of
which only dTORC1 appears to be affected by insulin.
Quantitative analysis dTOR complexes using
directed MS
We next used a directed MS approach in combination with
label-free quantification to estimate the relative distribution of
dTOR complexes in Drosophila cells (Schmidt et al, 2008;
Olsen et al, 2009) (Figure 4A).We used the average intensity of
the three most intense peptide ions per protein (TOP3) to
measure protein abundances in dTOR, CG3004/dGbL, dRap-
tor, dRictor purifications as proposed previously (Silva et al,
2006; Malmstrom et al, 2009).
dGbL represents the most abundant dTOR interactor
(Figure 4B; see also Supplementary Table 10). This is not
surprising as GbL is a common component of both mTORC1
and mTORC2 in human cells (Zoncu et al, 2011). dRaptor was
close in abundance to dGbL but 10-fold more abundant than
the dTORC2 components dRictor and dSIN1, suggesting that
dTORC1 is the most abundant dTOR complex in Drosophila
Kc167 cells. A similar abundance pattern for dTORC1 and
dTORC2 components was observed when dGbL was used as a
bait, confirming the results from the dTOR analysis.
In dRaptor purifications, the dTORC1 components dTOR,
dGbL and Lobe were the most abundant proteins. We also
detected the dTORC2 proteins dRictor and dSIN1 in dRaptor
purifications. However, dRictor levels were less than an
estimated 1% compared with the amount of the dTOR, Lobe
and dGbL. Similarly, when dRictor was analyzed as a bait, we
found besides the expected dTORC2 components dSIN1, dGbL
and dTOR also evidence for the presence of dTORC1
components dRaptor and Lobe. The amounts were about
two orders of magnitude below the amount of dRictor.
These results suggest that under the experimental conditions
applied including chemical cross-linking and targeted analysis,
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a small fraction of dTORC1 and dTORC2 components could be
detected in the same complexes.
Based on our quantitative results, it appears that both dTTT
components LqfR and CG16908 associate with dTOR to similar
amounts, which are a bit higher than the amounts of dTORC2
component dRictor (Figure 4B, upper left). Both proteins,
however, were not detected in the samples using either dGbL,
dRaptor or dRictor as bait proteins, suggesting that dTTT
represents a novel complex independent of the canonical
dTORC1 and dTORC2. Overall, the quantitative data from the
dTOR purifications indicate that dTORC1 is the most abundant
dTOR complexwe have identified in Kc167 cells (for details see
Supplementary Table 10).
Systematic functional analysis of the dInR/TOR
interaction proteome
We next wanted to study the potential roles of the identified
network components for controlling the activity of the dInR/
TOR pathway by systematic RNAi depletion experiments.
As a functional readout, we applied quantitative western
blotting to measure the changes in abundance of phosphory-
lated substrates of dTORC1 (Thor/d4E-BP, dS6K) and dTORC2
(dPKB) in RNAi-treated cells. Following hierarchical clustering
of the obtained RNAi phenotypes (mean intensity of at least
two independent experiments compared with EGFP control
RNAi, for details see also Supplementary Figure 4), we were
able to identify 16 proteins (out of 58) whose depletion
caused an at least 50% increase or decrease in the levels
of phosphorylated d4E-BP, S6K and/or PKB compared with
control GFP RNAi. As expected, the known components of the
dInR/Tor pathway were found among these proteins. For
instance, depletion of dTOR itself or its binding partner dGbL/
CG3004 strongly reduced the phosphorylation of dS6K, d4E-BP
and dPKB. Likewise, we found that depletion of dRaptor or
Rheb, two positive pathway regulators acting downstream of
dPKB, reduced the phosphorylation of the two dTORC1
substrates d4E-BP and dS6K, while phosphorylation of the
dTORC2 substrate dPKB was increased. Depletion of negative
regulators acting downstream of dPKB such as dTSC1 or
dTSC2 resulted in the opposite phenotypes. Phosphorylated
dPKB was also strongly reduced after depletion of positive
pathway regulators acting upstream of dPKB (Chico, p60,
dp110) or dRictor as reported previously (Sarbassov et al,
2005). Importantly, besides these established pathway com-
ponents, we also found several novel regulators within the
dInR/TOR interaction network (Figure 5A). For example, RNAi
A
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Figure 4 Analysis of dTOR complexes by quantitative AP–MS. (A) Workflow of AP–MS analysis for dTOR complex analysis. Peptide precursor m/z values obtained
from tryptic in silico digest of dTOR core components were used for inclusion list-LC/MS/MS experiments. Based on all successfully identified peptide features, label-free
quantification was performed and average signal intensities of the three most intense peptides (TOP3) were calculated to represent protein abundances. (B) Abundance
distribution of proteins identified in dTOR and dGbL (upper panel), dRictor and dRaptor purifications (lower panel) relative to the bait. The average TOP3 signal intensity
was used to infer protein abundances within individual AP–MS/MS experiments (data are listed in Supplementary Table 10). The average signal intensities of dTOR core
components in each of the indicated purifications were calculated relative to corresponding bait intensity (set to 10E5) from four purification experiments and are shown in
log scale in the bar chart. Error bars represent standard deviation in log scale.
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against the novel insulin-regulated dTORC1 component
Unkempt resulted in enhanced phosphorylation of the dTORC1
substrate d4E-BP (and to a lesser extent also of dS6K), which
suggests a negative role for Unkempt on dTORC1 activity. In
contrast, depletion of CG16908 and LqfR (see below) caused
hypo-phosphorylation of all dTOR substrates similar to dTOR
itself, suggesting a positive role for the dTTTcomplex on dTOR
activity. A representative western blot underlying these results
is shown in Figure 5B.
In summary, systematic RNAi-based phenotypic profiling
revealed key regulators within the InR/TOR interaction
proteome that represent promising new entry points for future
genetic and biochemical experiments toward an integrated
model on InR/TOR signaling.
dTTT components are required for cell growth
in vivo
Given the role of the dTTTcomplex as a positive regulator for
dTOR activity detected in Kc167 cells using RNAi, we next
tested whether it also plays a role in TOR-mediated cell growth
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CG16908 in Kc167 cells. Kc167 cells were treated with dsRNA as indicated and whole-cell lysates were analyzed after insulin stimulation. Individual or simultaneous
depletion of LqfR or CG16908 in Kc167 cells severely reduced the phosphorylation of S6KT398 (P-S6K), PKBS505 (P-PKB) and d4E-BPT37/47 (P-d4E-BP/Thor). Depletion
of Tor served as positive control and depletion of EGFP as negative control. The anti-a-tubulin (Tub) staining showed equal loading. Numbers on the right side indicate
molecular weight markers (in kDa).
The D. melanogaster InR/TOR pathway interaction proteme
T Glatter et al
8 Molecular Systems Biology 2011 & 2011 EMBO and Macmillan Publishers Limited
in vivo. Depletion of both dTTT components, CG16908 and
LqfR, in the Drosophila eye by the expression of short hairpin
UAS constructs using the ey-GAL4 system resulted
in a substantial decrease in eye size (Figure 6A). Likewise,
FLP-FRT-mediated mitotic recombination resulted in CG16908
and LqfR mutant clones with a similar reduced growth
phenotype as observed in dTOR mutant clones (Figure 6B).
In conclusion, the combined biochemical and genetic analysis
revealed dTTT as a dTOR-containing complex that is required
for the activity of both dTORC1 and dTORC2 and thus plays a
critical role in controlling cell growth.
Discussion
Information processing by cellular signaling pathways re-
quires the induced assembly and disassembly of specific
protein–protein interactions (PPIs) that constitute signaling
complexes. These in turn further associate into dynamic
molecular interaction networks. Here, we present the first
quantitative AP–MS/MS analysis of the insulin-regulated
interaction proteome constituting the Drosophila InR/TOR
signaling pathway, an evolutionary conserved pathway for the
control of cell growth.
The data revealed (1) a systematic data set on the dInR/TOR
interaction proteome; (2) new network components, which
suggest novel functional links of the canonical InR/TOR
pathway to other signaling systems; (3) a set of 22 hormone-
sensitive interactions that provide insights into the molecular
mechanism of intracellular information processing in response
to insulin and (4) a first detailed analysis of TOR complexes in
Drosophila, which revealed dTTT, a TOR complex required for
dTORC1 and dTORC2 activity and cell growth in vivo.
Systematic analysis of the Drosophila InR/TOR
signaling interaction proteome
Our biochemical knowledge on signaling complexes within
the metazoan InR/TOR pathway primarily has been inferred
from separate studies on signaling complexes from human
cells often analyzed in different cell types under varying
conditions. However, changes in cellular signaling complexes
upon insulin signaling are likely to occur in a concerted
fashion, acting atmultiple siteswithin the pathway. To date, no
systematic study has been performed to allow for a coherent
analysis and an integrated view on the InR/TOR interaction
proteome and its response to insulin. Drosophila offers a wide
range of genetic tools, which have been successfully used in
the past to identify critical pathway components and their
relationships underlying cell growth control. In contrast, only
few Drosophila studies have been reported to infer the
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Figure 6 Regulation of cell growth by LqfR/Tel2 and CG16908/Tti1. (A) Knockdown experiments of lqfR and CG16908 in the Drosophila eye. ey-GAL4 was used to
drive expression of short hairpin UAS constructs in the Drosophila eye. Depletion of lqfR (UAS-lqfRRNAi) or CG16908 (UAS-CG16908RNAi) resulted in a severe reduction
of eye size, suggesting that both proteins might act as positive growth regulators. A short hairpin construct against CG1315, which does not affect eye size, was used as
control (control). (B) Flp-FRT-based mutagenesis of lqfR and CG16908. Flp-FRT-mediated recombination was used to create mutant clones of Tor, lqfR or CG16908
(white tissue) surrounded by wild-type tissue (red tissue) in the Drosophila eye. In comparison to control clones (white tissue, first image; the FRT chromosome carries no
mutation), clones mutant for lqfR (white tissue, third image) or CG16908 (white tissue, fourth image) are severely smaller and show a growth disadvantage similar to
clones mutant for Tor (white tissue, second image), suggesting a positive growth regulating function of lqfR and the product of CG16908. Exact genotypes are (1) y w
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interactions of the genetically defined signaling proteins with
other proteins. Such studies are, however, highly needed as
proteins almost exclusively carry out their function as part of
multiprotein complexes formed by specific and tightly
regulated PPIs. Once identified, fly genetics could in turn
allow for the effective in vivo functional validation of new
protein interactions to generate novel hypotheses on the
mechanisms underlying cell growth by the InR/TOR network.
We therefore embarked on a systematic AP–MS/MS analysis
of the insulin-sensitive dInR/TOR interaction proteome to gain
systems level insights on the molecular basis of insulin
signaling in Drosophila cells. Applying stringent statistical
filtering, we identified 97 high confidence PPIs, of which 22 are
modulated by insulin. How does this information compare to
existing data? When compared with interaction data available
for Drosophila (http://www.droidb.org), we found only 12
overlapping interactions. Forty-nine interactions from our
study overlapped with orthologous interactions found in
humans (n¼39) and yeast (n¼10). In contrast, only three of
these 49 conserved interactions have been found in previously
published large-scale yeast two-hybrid screens (Giot et al,
2003; Stanyon et al, 2004), illustrating the advantage of the
AP–MS/MS approach over previously used technologies to
retrieve high quality protein interaction data on a larger scale
for the Drosophila proteome.
Signaling systems linked to the dInR/TOR
interaction proteome
Given its broad role in controlling cell growth in response to a
variety of environmental conditions including insulin and the
availability of nutrients and energy, it is likely that signaling by
the InR/TOR network may involve hitherto undiscovered
mechanisms of regulation and/or may extend toward other
concurrently active signaling systems. The presented InR/TOR
interaction proteome consists of a number of proteins that
have specific roles in cell signaling. These include proteins
involved in G-protein signaling, protein phosphorylation,
transcription, translation and ubiquitin-dependent degrada-
tion. A number of these proteins have not yet been associated
with the canonical pathway model and thus may link the InR/
TOR pathway to other signaling systems including the JNK/
MAPK (MSN, Pellino) and LKB1/AMPK (dNUAK1) pathways.
In addition, the presented interactions may also point to novel
signaling mechanisms such as ubiquitin-dependent degrada-
tion within the dInR module (Mib-2, SkpA, Pall, Lin19) or the
dTOR module (Unkempt, Cul-3, COP9). These new linkages
provide specific routes for further hypothesis driven genetic
experiments to address their functional importance for growth
control by the InR/TOR pathway.
Insulin regulation of the InR/TOR interaction
proteome
Most cellular processes strongly depend on the coordinated
formation and disassembly of protein complexes. Using a
recently developed method for label-free quantitative MS
analysis of protein complexes (Rinner et al, 2007), we found
that 25% of the quantified interactions are regulated by insulin
(22% of all identified PPIs). Insulin led to both the induction
and dissociation of signaling complexes. Major hormone-
induced rearrangements in the interaction network could be
observed within membrane proximal InR/Chico/PI3K com-
plexes, 14-3-3 containing complexes and in dTORC1, but not in
dTORC2 complexes. For the dInR complexes, the observed
changes reflect to a large extent the situation also observed for
the human InR complex, where InRonce activated recruits and
phosphorylates IRS which in turn allows recruitment of PI3K
via SH2 domains present in the regulatory PI3K subunit p85
(Virkamaki et al, 1999). Furthermore, we found that the ring-
finger E3 ubiquitin ligase Mib-2 dissociates from Chico
complexes upon insulin signaling. This raises the interesting
question whether Mib-2 plays a role in negatively regulating
Chico levels via ubiquitin-dependent degradation in the
absence of insulin.
Within the dTORmodule, we noted several interactions that
are insulin sensitive. These include the insulin-induced
dissociation of the Drosophila PRAS40 homolog Lobe from
dTOR. In human cells, PRAS40 binds to mTOR in an insulin-
dependent manner and may act as a negative regulator of
TORC1 in the absence of insulin (Sancak et al, 2007; Vander
Haar et al, 2007). Our data suggest that this mechanism is
conserved in Drosophila cells. Three different proteins became
recruited to dTOR complexes upon insulin treatment: the two
dTORC1 substrates d4E-BP, dS6K and Unkempt, a novel
dTORC1-associated protein identified in our study. Enhanced
recruitment of dS6K and d4E-BP to dTOR complexes could
represent a plausible mechanism to enhance phosphorylation
of these substrates upon insulin signaling. 4E-BP plays an
evolutionary conserved role in suppressing translation via
complex formation with the eukaryotic translation initiation
factor 4E (eIF-4E) when nutrients or insulin are low. In human
cells, it has been shown that mTOR can phosphorylate 4E-BP1,
which causes dissociation from eIF-4E and subsequent release
of translational suppression (Mamane et al, 2006). Consistent
with this model, we found complex formation between d4E-BP
and deIF-4E to be decreased when cells were stimulated with
insulin. Insulin increased the binding of the ring-finger protein
Unkempt to dTORC1. Unkempt has not been linked to TOR
signaling in other species. The observed insulin-regulated
recruitment of Unkempt to dTORC1 represents a specific entry
point for further functional studies on the control of dTOR
signaling by this novel dTORC1 component.
Taken together, systematic label-free quantification as
performed in this study reliably revealed insulin-regulated
changes in several signaling modules. The observed changes
demonstrate the evolutionary conservation of signaling
dynamics observed in human cells but also point to new
insulin controlled interactions, suggesting new molecular
mechanism in insulin signal transduction.
TORC1 and TORC2 complexes in Drosophila
TOR is an evolutionary conserved regulator of cell growth and
has been studied in a wide range of species. Over the years,
building on the data mainly obtained from biochemical studies
in human and yeast cells, it has been proposed that TOR forms
two major conserved complexes TORC1 and TORC2 (Wulls-
chleger et al, 2006; Bhaskar and Hay, 2007). The detailed
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composition of Drosophila TOR complexes has not been
analyzed. In this study, we used high-density protein interac-
tion data from multiple reciprocal AP–MS/MS experiments
involving new quantification methods to determine dTOR
complex composition and estimated the relative abundance of
dTOR complexes in Drosophila Kc167 cells using directed MS.
Overall, the quantitative data from the dTOR purifications
indicate that dTORC1 is the most abundant dTOR complex in
KC167 cells (for details see Supplementary Table 10). The
identified complexes show similarities but also differences to
the TOR complexes described in humans (Hurov et al, 2010;
Zoncu et al, 2011). dTORC1, the most abundant complex,
contains all Drosophila orthologs of mTORC1 components
(dTOR, dRaptor, Lobe, dGbL). DEPTOR, another protein
associated with mTORC1, is not encoded by the Drosophila
genome. Instead, we found Unkempt, a poorly characterized
ring-finger protein, which binds dTORC1 in response to
insulin. In addition, our systematic RNAi experiments suggest
that Unkempt, similar to TSC1/2, may act as a negative regu-
lator of dTORC1 activity in Drosophila cells. No biochemical or
functional links to dTOR have been established yet. However,
Unkempt has been reported to be among the strongest
transcriptionally upregulated genes following inhibition of
dTOR with rapamycin in Drosophila S2 cells (Guertin et al,
2006). These results, together with our data, hint at a
regulatory feedback relationship between Unkempt and dTOR.
Likewise, dTORC2 contains all orthologsmTORC2 components
except DEPTOR and PROTOR, for which no orthologs are found
in the Drosophila genome. Both DEPTOR and PROTOR appear
during higher vertebrate evolution (they are absent in the two
sequenced Ciona species, string-db.org). These findings suggest
that TORC1 and TORC2 are composed of evolutionary ancient
core complexes, which acquired further functionality during
metazoan evolution by the association of additional proteins
such as DEPTOR, PROTOR or Unkempt in the case of dTORC1.
Our quantitative analysis using directedMS showed that the
majority of dTORC1 and dTORC2 complexes exist as two
separate complexes. We also obtained evidence from multiple
independent purifications that a small fraction of dTORC1-
specific proteins such as dRaptor are associated with TORC2
components dSIN1 and dRictor, which was not observed in
previous studies on the corresponding human or yeast TOR
complexes. In contrast to previous studies, we used chemical
cross-linking and directed proteomics to enhance the sensi-
tivity in our analysis, which may account for the observed
differences. Genetic experiments in Drosophila and biochem-
ical experiments in human cells suggest that TOR complexes
can exist as dimers (Takahara et al, 2006; Zhang et al, 2006;
Yip et al, 2010). Our AP–MS results could be explained by
the existence of a small fraction TORC1/TORC2 heterodimers.
dTTT, a conserved dTOR complex required for
dTORC1/dTORC2 activity and cell growth
This study revealed the existence of a third dTOR complex here
referred to as dTTT. Based on orthology information (see
Supplementary Table 8) and reciprocal AP–MS and coimmu-
noprecipitation data (see Supplementary Figure 3), we
propose that dTTT contains, besides dTOR, the gene product
of CG16908, LqfR, Pontin, Reptin and Spaghetti. These
proteins were specifically identified in dTOR and CG16908
purifications but not in purifications using any of the other
dTORC1 and dTORC2 complex components, strongly suggest-
ing that they form complexes independent of dTORC1 and
dTORC2. Sequence inspection revealed that CG16908 and LqfR
represent orthologs of Tti1 and Tel2 from fission yeast and
human cells. In agreement with our results on the Drosophila
complex, previous studies in fission yeast and human cells
showed complex formation between Tti1, Tel2 and PIK-related
kinases including TOR (Hayashi et al, 2007; Hurov et al, 2010;
Kaizuka et al, 2010). Recent studies on human Tel2 complexes
demonstrated the presence of human Pontin and Reptin
(Horejsi et al, 2010; Takai et al, 2010), which together with
our results suggests that Tel2-TOR containing complexes are
probably larger than originally described. What is the role of
Tel2 complexes for TOR signaling? We found that flies mutated
or silenced for CG16908 or LqfR showed reduced growth
similar to dTORmutant flies.We also showed that the presence
of CG16908 or LqfR is required for substrate phosphorylation
by both dTORC1 and dTORC2 complexes, suggesting that the
observed growth phenotypes result from lowered dTORC1 and
dTORC2 activities in cells lacking functional dTTTcomplexes.
The detailed mechanisms, how dTTT may affect dTORC1 and
dTORC2 activity is not clear yet, butmay involve the regulation
of dTOR protein levels. It has been shown that mice lacking the
TTTcomponent Tel2 have decreased the levels of mTOR (Takai
et al, 2007). However, it remains to be seen whether silencing
of the dTTT components CG16908 and LqfR cause a similar
decrease in dTOR protein levels in Drosophila cells. Recent
biochemical studies in mammalian cells proposed a model in
which Tel2 complexes are necessary for the proper folding of
mTOR (Takai et al, 2010). The biochemical details are largely
unknown, but it has been proposed that Tel2 may act as a
scaffold to coordinate HSP90 or the R2TP/prefoldin chaper-
ones in the assembly of PIK-related kinase complexes (Horejsi
et al, 2010; Takai et al, 2010). The R2TP/prefoldin complex
contains RPAP3, the human ortholog of Spaghetti, which we
also found associated with dTOR complexes, andwhich shares
components with the prefoldin containing URI/RMP complex
previously linked to nutrient signaling controlled by mTOR
(Gstaiger et al, 2003).
In conclusion, this work represents the first systematic
quantitative AP–MS/MS analysis of the insulin-regulated
interaction proteome of the Drosophila InR/TOR signaling
pathway. Given the high degree of evolutionary conservation
of this central growth control pathway, this study represents a
valuable framework for future focused studies using genetic
and biochemical approaches in a variety of species.
Materials and methods
Expression constructs and cell line generation
DrosophilaORFs of interest were PCR amplified fromDrosophila cDNA
pools using the Phusion Polymerase (Finnzymes), sequenced and
inserted into a Gateway compatible entry vector (pENTR-D-TOPO,
Invitrogen). Using LR recombination, the ORFs were transferred from
the entry vector into in-house designed expression vectors allowing
inducible expression of the bait protein fused to a triple hemagglutinin
(HA) affinity-tag from the Metallothionein promoter. For generation of
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inducibly expressing cell lines, the expression construct was trans-
fected using the Transfecten reagent (Qiagen) toDrosophilaKc167 cells
cultivated in Schneiders S2 medium (Invitrogen) containing 10% FBS
and 50mg/ml penicillin, 50mg/ml streptomycin. In all, 10mg/ml
Blasticidin was used for selection for 5 weeks. Cell pools were tested
for positive expression by western blotting using anti-HA antibodies
(Covance). For bait expression, the cells were exposed to 600mM
CuSO4 overnight.
Affinity purification
Prior to AP, Kc167 cells were grown in shaking flasks in Schneider S2
medium containing 10% FBS. The cells were serum starved in
2% FBS overnight and bait expressionwas induced using 600mMCuSO4
for at least 16h. Cells were either treated with 100nM insulin
for 20min or left untreated before harvest. For AP, the cell pellets
were lysed on ice for 30min in 10ml HNN (50mM HEPES pH 7.5,
5mM EDTA, 250mM NaCl, 0.5% NP-40, 1mM PMSF, 50mM NaF,
1.5mMNa3VO4, protease inhibitor cocktail (Roche), 3mM DSP) using a
tight-fitting Dounce homogenizer. Following cell lysis, reactive DSP was
quenched by adding 1ml 1M Tris, pH 7.5. Insoluble material was
removed from the lysate by centrifugation and the supernatant was
precleared using 100ml Protein A-Sepharose (Sigma) for 1h at 4 1C on
a rotating shaker. After removal of the Protein A-Sepharose, 100ml
anti-HA agarose (Sigma) was added to the extracts and incubated
for 4h at 4 1Con a rotating shaker. Immunoprecipitateswerewashed 4#
with 20 bedvolumes of lysis buffer and 3# with 20 bedvolumes
of buffer without detergent and protease inhibitor. The proteins
were released from the beads by adding 3# 150ml 0.2M Glycine,
pH 2.5. Following neutralization using 100ml 1M NH4CO3, the
eluates were treated with 5mM TCEP for 30min at 37 1C and alkylated
with 10mM Iodacetamide for 30min at RT in the dark. For tryptic digest,
1mg trypsin was added to the eluate and incubated at 37 1C overnight.
The tryptic digest was acidified to pHo3 using TFA and purified using
C18Microspincolumns (Harvard Apparatus) according to the protocol of
the manufacturer. Dried peptides were resolved in 0.1% formic acid
containing 1% acetonitrile and injected into the mass spectrometer.
LC–MS/MS analysis
LC–MS/MS analysis of affinity-purified samples was performed on an
LTQ-FT-ICRmass spectrometer (ThermoElectron),whichwas connected
to an online electrospray ion source. Peptide separation was carried out
using an Eksigent Tempo nano LC System (Eksigent Technologies)
equipped with a RP-HPLC column (75mm# 15 cm) packed in-house
with C18 resin (Magic C18 AQ 3mm; Michrom BioResources) using a
linear gradient from 96% solvent A (0.15% formic acid, 2% acetonitrile)
and 4% solvent B (98% acetonitrile, 0.15% formic acid) to 35% solvent
B over 60min at a flow rate of 0.3ml/min. The data acquisitionmodewas
set to obtain one high-resolutionMS scan in the ICR cell at a resolution of
100 000 full width at half maximum (at m/z 400) followed by MS/MS
scans in the linear ion trap of the three most intense ions (overall cycle
time of 1 s). To increase the efficiency of MS/MS attempts, the charged
state screening modus was enabled to exclude unassigned and singly
charged ions. Only MS precursors that exceeded a threshold of 150 ion
countswere allowed to triggerMS/MS scans. The ion accumulation time
was set to 500ms (MS) and 250ms (MS/MS) using a target setting of 106
(forMS) and 104 (forMS/MS) ions. After every sample, a peptidemixture
containing 200 fmol of [Glu1]-Fibrinopeptide B human (Sigma, Buchs)
was analyzed by LC–MS/MS to constantly monitor the performance of
the LC–MS/MS system.
For directed mass spectrometry, LC–MS/MS experiments were
carried out on an Orbitrap Velosmass spectrometer coupled online to a
nano-LC systems (Proxeon Biosystems) and an electrospray ion source
(Proxeon Biosystems). LC settings (flow rates and buffer composition)
were identical to those described before. Survey full MS spectra were
acquired in the Orbitrap with a resolution of 60 000 full width at half
maximum (at m/z 400), followed by MS/MS spectra acquired in the
linear ion trap of the five most intense ions. Another five MS/MS
spectra were triggered on target m/z derived from in silico digests of
dTOR core components (dTOR, dRaptor, dRictor, CG3004/dGbL,
dSIN1, Lobe, dS6k, Thor/d4E-BP, CG16908, Unkempt, LqfR) using
trypsin as protease. The charge state screening modus was enabled to
exclude singly charged and uncharged ions. General settings were
similar to FT-MS measurements, except CID-based fragmentation was
triggered when the precursor exceeded 500 ion counts. The dynamic
exclusion duration was set to 15 s. The ion accumulation time was set
to 300ms (MS) and 50ms (MS/MS). All MS raw data can be accessed
via the following ftp site:
ftp://ftp:a@ftp.peptideatlas.org/pub/PeptideAtlas/Repository/
PAe001966/ and ftp://ftp:a@ftp.peptideatlas.org/pub/PeptideAtlas/
Repository/PAe001967/
MS2 peptide assignment
Acquired MS2 scans were searched against the Drosophila Flybase
database version 5.7 using the SORCERER-SEQUEST (TM) search
algorithm, which was run on the SageN Sorcerer (Thermo Electron).
Data represented in Supplementary Table 9 were searched using
MASCOT against a decoy database. In silico trypsin digestion was
performed after lysine and arginine (unless followed by proline)
tolerating two missed cleavages in fully tryptic peptides. Database
search parameters were set to allow phosphorylation (þ 79.9663Da)
of serine, threonine and tyrosine as a variable modification and
carboxyamidomethylation (þ 57.021464Da) of cysteine residues as
fixed modification. Furthermore, a variable modification of lysine
residues (þ 145.01975) from the carboxyamidomethylated cleaved
DSP cross-linker was considered. The fragment mass tolerance was set
0.5Da and the precursor mass tolerance to 10 p.p.m. Search results
were evaluated on the Trans Proteomic Pipeline using Peptide Prophet
(v3.0) and Protein Prophet (Keller et al, 2002; Nesvizhskii et al, 2003).
For SEQUESTsearches, a minimum peptide probability corresponding
to o5% false discovery rate (FDR) was required for protein
identification. For MASCOT searches, only peptides with a scores of
31 corresponding to a 5% FDR were accepted.
Filtering for specific interaction partners
SAINT (Breitkreutz et al, 2010; Choi et al, 2010) was used to assign
confidence scores to observed PPIs. SAINT performs statistical
modeling of the quantitative (in this work, using normalized spectral
counts) bait–prey associationmatrix. It generates distributions for true
and false interaction and reports the probability score for classification
into the two categories. To take advantage of the control purifications
(using GFP as a bait protein) generated in parallel with experimental
purifications using bait proteins, the data were analyzed using SAINT
2.0 version of the algorithm (Choi et al, 2010). In SAINT 2.0, the false
interaction distribution for each prey protein is learnedwith the help of
the quantitative prey abundance data observed in control purifica-
tions. After simultaneously learning both true and false interaction
distributions from the data, the method determines whether the
observation of a prey protein in a particular experimental purification
indicates true interaction based on that prey’s abundance measure-
ment relative to the prey-specific false and true interaction distribu-
tions (Figure 1B) using Bayes’ rule:
PðTRUEjXÞ ¼ PðXjTÞ PðTÞ
PðXjTÞ PðTÞ þ PðXjFÞ PðFÞ PðTRUEjXÞ
¼ PðXjTÞ PðTÞ
PðXjTÞ PðTÞ þ PðXjFÞ PðFÞ ð1Þ
Because bait proteins were profiled in two biological replicates for
each condition (insulin-treated and -untreated AP–MS experiments),
the final SAINT score is computed as an average of the individual
probabilities across the replicates. Bait–prey interactions are sorted in
a decreasing order of SAINT scores. The FDR associated with a
threshold can be approximated from the probabilities in the selected
set of interactions (see also Figure 1B):
FDR ðp&Þ ¼
P
i1ðpXp&Þ#ð1' piÞP
i1ðpiXp&Þ FDR ðp&Þ
¼
P
i1ðpXp&Þ#ð1' piÞP
i1ðpiXp&Þ ð2Þ
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In running this data set, the quantitative data for both conditions were
pooled into a single data set, where identical baits in different
conditions were treated as independent baits, and SAINTwas applied
to this data. High confidence interactions were selected to meet the
requirement that the local FDR is controlled at (1–x)# 100% (posterior
probability Xx). In the first step, network components were defined
based on a SAINT posterior probability of 0.99. In addition to the
SAINT filtering, which removed the majority of contaminants, we
excluded 17 known contaminant proteins (Supplementary Table 3),
resulting in the identification of 58 high confidence network
components. Protein interactions between high confidence network
components were included in the network model, if SAINT probability
was at least 0.8. The filtered protein interaction data from this publica-
tion have been submitted to the IMEx (http://www.imexconsortium.
org) consortium through IntAct (Aranda et al, 2010) and assigned the
identifier IM-15821.
Detection of insulin-sensitive protein interaction
and analysis of dTOR complexes using label-free
quantification
Differences in complex composition between stimulation conditions
were quantified based on the ratio of MS1 signal intensity under
insulin-stimulated and -unstimulated conditions. In order to increase
significance of apparent differences, a three-step dilution series was
measured by mixing tryptic peptides from insulin-starved samples
with peptides from the corresponding insulin-stimulated samples
as described in Rinner et al (2007). MS1 signal intensities obtained
for each peptide mapping to a specific protein were grouped accord-
ing to the dilution factor (0, 30, 100% insulin-treated sample). The
median signal intensity of the 10 most intense peptide precursors
of the individual bait proteins were used to calculate factors that were
used to normalize prey MS1 abundance profiles relative to the bait
abundance. Individual peptide dilution profiles were accepted for
further analysis when aligned MS1 features were detected at least
twice within the profile. Otherwise, the individual peptide profile was
discarded from analysis. In cases where only two data points were
observed, the profile was extrapolated to cover a full profile. On each
valid peptide profile, a linear regression from dilution factor to MS1
signal intensity was performed to determine the difference between
the theoretical and observed protein abundance profile. The Pearson
product-moment correlation coefficient (r) was used to represent the
quality of profiles, indicating insulin-regulated interactions. Data
points differing by 42 s.d. from the average intensity for a specific
dilution point were discarded as outliers before linear regression.
Profiles showing a linear regression with r40.5 were accepted. The
slope inclination of the profile indicates the enrichment of an
interaction between insulin-stimulated and -unstimulated condition.
Protein profiles were considered as changed when the enrichment
factor of the same bait–prey protein profile in both replicate
experiment were 41.5 (enriched) or o0.67 (depleted). The validity
of a 1.5-fold cutoff was evaluated using triplicate experiments followed
by t-test analysis (see Supplementary Figure 1 and Supplementary
Table 9).
For analysis of dTOR complexes, defined dTOR core components
(dTOR, dRaptor, dRictor, CG3004/dGbL, SIN1, Lobe, CG16908,
Unkempt, LqfR) were in silico digested. Predicted double and triply
charged tryptic fragment m/z were used as target masses for inclu-
sion list LC–MS/MS analysis. Profile mzXML data for each AP
experiment (four purifications per bait protein from insulin-treated
and -untreated cells) were used for label-free quantification using
Progenesis software Version 3.0 (Nonlinear Dynamics Limited). The
raw data were first normalized by the Median TIC. In a second step,
the three most intense peptide signal intensities of aligned peptides
matching to dTOR core components were extracted from LC–MSmaps
(TOP3) and the average signal intensity of the TOP3 peptides for
each protein in each AP–MS experiment was calculated. The average
TOP3 intensities of each protein were then normalized by the average
TOP3 intensity of the respective bait protein in each AP–MS experi-
ment. The data were further processed with the Spotfire Decision Site
program (TIBCO).
Analysis of protein interaction data
Protein interaction data fromAP–MS/MS experimentswere assembled
into PPI network models using Cytoscape 2.6.1 (http://www.cytoscape.
org). GO annotations have been retrieved from PANTHER (http://
www.pantherdb.org). To identify known interactions, all PPI data
were compared against the information available from the Biogrid
database (http://www.thebiogrid.org) version 2.0.53 and DroID
(http://www.droidb.org) version 4.0. Human and yeast orthologs have
been retrieved from the Ensemble database using biomart version 0.7
(http://www.biomart.org) and Blast searches (http://www.expasy.
ch/tools/blast). Orthologous interactions have been searched using
DroID (http://www.droidb.org), the yeast biogrid database (http://
www.biogrid.org) and an in-house database containing 61263 human
protein interactions from various databases (BIND, DIP, IntAct, HPRD)
and published literature (Ramani et al, 2005; Rual et al, 2005; Stelzl et al,
2005).
Fly genetics
The UAS hairpin lines 25 707 (UAS-lqfRRNAi), 47096 (UAS-CG1315RNAi)
and 16908R-1 (UAS-CG16908RNAi) were obtained from the Vienna
Drosophila RNAi Center and the National Institute of Genetics (Japan),
respectively. CG16908MB01483 (Metaxakis et al, 2005) and the GAL4
driver line ey-GAL4 (Hazelett et al, 1998) were from the Bloomington
Drosophila Stock Center. The alleles lqfRD117 (Lee et al, 2009) and
TOR2L1 (Oldham et al, 2000) as well as the FRT insertions FRT40A and
FRT82B (Xu and Rubin, 1993) and the lines y w ey-FLP; FRT40A, wþ ,
cl2L3/CyO and y w ey-FLP; FRT82B, wþ , cl3R3/TM6B, Tb, Hu, yþ
(Newsome et al, 2000) have been described. Lines carrying mutations
on FRTchromosomes were established by meiotic recombination.
For Figure 6A, ey-GAL4 females have been crossed to males carrying
the different UAS transgene insertions. For Figure 6B, y w ey-FLP;
FRT40A, wþ , cl2L3/CyO or y w ey-FLP; FRT82B, wþ , cl3R3/TM6B, Tb,
Hu, yþ females have been crossed to males of the following lines:
(1) y w; FRT82B/TM6B, Tb, Hu, yþ , (2) y w; FRT40A, Tor2L1/CyO,
(3) y w; FRT82B, lqfRD117/TM6B, Tb, Hu, yþ , (4) y w; FRT82B,
CG16908MB01483/TM6B, Tb, Hu, yþ .
Generation of dsRNA
Gene fragments fused to T7 promoters were amplified by PCR (for
primer sequences see Supplementary Table 11) and subjected to
in vitro transcription using the Ambion Megascript Kit.
Transfection of dsRNA into Drosophila KC cells
and cell lysis
In all, 106 Kc cells were plated in 1ml serum-free medium (six-well
plate) and incubated with 10 mg dsRNA. After 30min, serum-contain-
ing medium was added. Five days after transfection, the cells were
stimulatedwith 40 mg insulin (Sigma) for 10min, washedwith PBS and
lysed on ice for 30min in 30ml lysis buffer (120mMNaCl, 50mM Tris–
HCl (pH 8), 20mM NaF, 1mM EDTA, 6mM EGTA, 15mM Na4P2O7,
1mM benzamidine, 1% NP-40) supplemented with 30mM para-
nitrophenylphosphate and 30mM b-glycerolphosphate. After centri-
fugation, the whole-cell lysates were analyzed by SDS–PAGE.
Immunoblotting and quantification of band signal
intensities
Hybond ECL membranes (GE Healthcare) and Immobilon Western
detection reagent (Millipore) were used for immunoblotting. The
following antibodies were used: rabbit anti-phospho-Drosophila p70
S6K (Thr398; Cell Signaling) at 1:9.000, rabbit anti-phospho-AKT
(Ser473; Cell Signaling) at 1:9.000, rabbit anti-phospho-4E-BP1
(Thr37/46; Cell Signaling) at 1:1.000 and mouse anti-a-tubulin
(DM1A; Sigma) at 1:100.000.
Scanned images of the immunoblotswere processedwith ImageJ for
quantification of band signal intensities. Therefore, individual bands
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were selected by a rectangle and the total signal intensity was
determined after correcting each pixel within the rectangle by a
background intensity value. This valuewas obtained by calculating the
average pixel intensity of a region directly above or below the selected
rectangle. Subsequently, the signal intensities of the bands corre-
sponding to P-S6K, P-PKB and P-d4E-BP were further corrected for
loading differences by normalization with the corresponding tubulin
bands. For the heat map in Figure 5, the signal intensities of the bands
corresponding to P-S6K, P-PKB and P-d4E-BP were averaged for each
RNAi experiment after normalization to EGFP RNAi experiments,
which were set to 100%.
Note: The two bands, which are recognized by the anti-phospho-
PKB antibody, represent the two phosphorylated PKB isoforms and
have been quantified simultaneously.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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